Department of Urology, Sheba Medical Center, Ramat Gan, Israel.
Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
World J Surg Oncol. 2017 Nov 2;15(1):193. doi: 10.1186/s12957-017-1257-6.
Positive surgical margins (PSM) are recognized as an adverse prognostic sign and are often associated with higher rates of local and systemic disease recurrence. The data regarding the oncological outcome for PSM following radical nephrectomy (RN) is limited. We examined the predictive factors for PSM and its influence on survival and site of recurrence in patients treated with RN for renal cell carcinoma (RCC).
Clinical, pathologic and follow-up data on 714 patients undergoing RN for kidney cancer were analyzed. Secondary analysis included 44 patients with metastatic RCC upon diagnosis who underwent cytoreductive nephrectomy (CRN). Univariate and multivariable logistic regression models were fit to determine clinicopathologic features associated with PSM. A Cox proportional-hazards regression model was used to test the independent effects of clinical and pathologic variables on survival.
PSM was documented in 17 cases (2.4%). PSM were associated with tumour size, advanced pathologic stage (pT3 vs. ≤ pT2) and presence of necrosis. On multivariate analysis, cancer-specific survival (CSS) was associated with tumour stage, size, presence of necrosis and PSM. PSM was also associated with local recurrence but not distant metastasis or overall survival (OS). CSS and OS were comparable between the PSM and metastatic RCC groups, but significantly lower than the negative margin group.
The prevalence of PSM following RN is rare. Pathological data, including advanced stage (> pT2), tumour necrosis and tumour size, are associated with the presence of PSM. PSM is associated with tumour recurrence and CSS. Patients with PSM are a potential group for adjuvant therapy or for more careful and thorough follow-up following surgery.
阳性切缘(PSM)被认为是预后不良的标志,通常与局部和全身疾病复发率较高相关。根治性肾切除术(RN)后 PSM 的肿瘤学结果数据有限。我们检查了 PSM 的预测因素及其对接受 RN 治疗的肾细胞癌(RCC)患者生存和复发部位的影响。
分析了 714 例接受 RN 治疗肾癌的患者的临床、病理和随访数据。二次分析包括 44 例初诊时转移性 RCC 患者行减瘤性肾切除术(CRN)。使用单变量和多变量逻辑回归模型确定与 PSM 相关的临床病理特征。使用 Cox 比例风险回归模型检验临床和病理变量对生存的独立影响。
17 例(2.4%)记录到 PSM。PSM 与肿瘤大小、高级别病理分期(pT3 与 ≤ pT2)和坏死有关。多变量分析显示,肿瘤特异性生存率(CSS)与肿瘤分期、大小、坏死和 PSM 有关。PSM 也与局部复发有关,但与远处转移或总生存率(OS)无关。PSM 组与转移性 RCC 组的 CSS 和 OS 相当,但明显低于阴性切缘组。
RN 后 PSM 的发生率较低。病理数据,包括晚期(> pT2)、肿瘤坏死和肿瘤大小,与 PSM 的存在相关。PSM 与肿瘤复发和 CSS 相关。PSM 患者可能是辅助治疗或术后更仔细和彻底随访的潜在人群。